Showing 1861-1870 of 2526 results for "".
- Allegro Ophthalmics Receives Approval from FDA for Design of Phase 2b/3 Clinical Trial of Risuteganib for the Treatment of Intermediate Dry AMDhttps://modernod.com/news/allegro-ophthalmics-receives-approval-from-fda-for-design-of-phase-2b3-clinical-trial-of-risuteganib-for-the-treatment-of-intermediate-dry-amd/2481527/Allegro Ophthalmics announced that the company has received agreement from the FDA under a Special Protocol Assessment (SPA) for the design of its phase 2b/3 clinical trial of risuteganib (Luminate) for the treatment of intermediate, dry age-related macular degeneration (AMD).
- Kala Receives FDA Fast Track Designation for Human MSC-S Therapy for Persistent Corneal Epithelial Defecthttps://modernod.com/news/kala-pharmaceuticals-receives-fda-fast-track-designation-for-kpi-012-a-human-msc-s-therapy-for-persistent-corneal-epithelial-defect/2481526/The FDA has granted Fast Track designation for Kala Pharmaceuticals' human mesenchymal stem cell secretome (MSC-S) therapy (KPI-012) for the treatment of persistent corneal epithelial defect (PCED). “There is a significant unmet need for patients suffering from PCED, whic
- Researchers Explain How Reading Might Contribute to Myopiahttps://modernod.com/news/researchers-explain-how-reading-might-contribute-to-myopia/2481520/Researchers at the State University of New York (SUNY) are publishing a paper explaining how reading might contribute to myopia. In a paper that will be published in the Journal of Vision, scientists demonstrate that the images formed by our eyes during reading lack
- Cellusion Announces First Patient Transplanted iPSC-Derived Corneal Endothelial Cell Substitute (CLS001)https://modernod.com/news/cellusion-announces-first-patient-transplanted-ipsc-derived-corneal-endothelial-cell-substitute-cls001/2481493/An iPS cell-derived corneal endothelial cell substitute (CLS001) was transplanted to the first patient, according to Cellusion. Research collaborator, Shigeto Shimmura, MD, PhD, Professor of Fujita Health University and Keio University in Japan, provided details of the procedure&nb
- Researchers: Night Vision Tests in AMD Precisely Localize Disease Mechanismshttps://modernod.com/news/researchers-night-vision-tests-in-amd-precisely-localize-disease-mechanisms/2481479/Researchers at the University of Alabama at Birmingham discovered that night vision tests at a specific location in the retina will be suitable for assessing treatments and preventions for age-related macular degeneration (AMD), according to a university
- CooperVision Launches Major US Myopia Control Advocacy and Education Campaignhttps://modernod.com/news/coopervision-launches-major-us-myopia-control-advocacy-and-education-campaign/2481474/CooperVision has unveiled a multifaceted consumer and professional marketing campaign to protect children’s vision and advance myopia control education in the United States to kick off Vision Expo East 2023. The “Make Children’s Sight Your Fight” initiative is rooted in ne
- Researchers Discover Therapeutic Target to Aid in Glaucoma Treatmenthttps://modernod.com/news/researchers-discover-therapeutic-target-to-aid-in-glaucoma-treatment/2481470/Indiana University School of Medicine researchers have identified a new therapeutic target that could lead to more effective treatment of glaucoma, according to an article posted on the university website.
- TearRestore Announces Positive Clinical Trial Results for Patients with Dry Eye Diseasehttps://modernod.com/news/tearrestore-announces-positive-clinical-trial-results-for-patients-with-dry-eye-disease/2481456/TearRestore announced positive toptine results of a study conducted by the University of Colorado titled, “The Effect of Warm Compress Therapy on Dry Eye Disease,” using the TearR
- Pioneers in Retinal Gene Therapies Awarded International Harrington Prizehttps://modernod.com/news/pioneers-in-retinal-gene-therapies-awarded-international-harrington-prize/2481453/The tenth annual Harrington Prize for Innovation in Medicine has been jointly awarded to Jean Bennett, MD, PhD, the F.M. Kirby Emeritus Professor of Ophthalmology and Cell and Developmental Biology at the Perelman School of Medicine at the University of Pennsylvania;
- Zeiss Acquires All Shares of Tooz, Maker of Augmented Reality Opticshttps://modernod.com/news/zeiss-acquires-tooz-maker-of-augmented-reality-and-virtual-reality-glasses/2481447/Zeiss announced it has acquired the shares of the joint venture tooz technologies, which was founded together with Deutsche Telekom in 2018 and is developer of high-tech optics in the area of augmented reality. Until now, Zeiss and Deutsche Telekom held 50% of the shares in the sta